Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
City Of Hope National Medical Center · Spinal Cord Injury BC · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
419
total citations
- FWCI
- 39.73
- Percentile
- 100%
- References
- 28
Citations per year
Authors
20Topics & keywords
Topics
Keywords
- Medicine
- Follicular lymphoma
- Refractory (planetary science)
- Internal medicine
- Clinical endpoint
- Progressive disease
- CD20
- Follicular phase
No related works found for this paper.